This site is for US residents only.
A significant reduction of 80% in triglycerides from baseline was seen at 10 months
Explore the resultsFewer people had acute pancreatitis attacks: 2 (8%) compared with 5 (20%) on placebo
See the dataThe only FCS injection that is just one dose every 3 months
Uncover the dosing schedule*The clinical study included an evaluation of acute pancreatitis events that occurred in patients taking Redemplo compared to those taking placebo. Redemplo has not been proven to reduce acute pancreatitis events.
†Redemplo 25 mg reduced median triglycerides by 80% (from 2008 mg/dL to 443 mg/dL) compared with 17% for placebo (from 2053 mg/dL to 1614 mg/dL).
REDEMPLO® (plozasiran) is an injectable prescription medicine used together with a low-fat diet to reduce triglycerides (fat in the blood) in adults with a condition that keeps the body from breaking down fats called familial chylomicronemia syndrome (FCS).
Before you start using REDEMPLO, tell your healthcare provider about all your medical conditions, including if you are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. It is not known if REDEMPLO could harm your unborn baby, or if it passes into your breast milk and could harm your breastfeeding baby.
Tell your healthcare provider or pharmacist about any prescription and over-the-counter medicines, vitamins, or herbal supplements you take.
The most common side effects of REDEMPLO include increased blood sugar levels, headache, nausea, and injection site reactions (pain, redness, or swelling).
These are not all the possible side effects of REDEMPLO. Tell your healthcare provider or treatment team if you have any side effect that bothers you or that does not go away.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/safety/medwatch, or call 1-800-FDA-1088.